CIK: 0001535610
Total reported value
$45.1M
Reporting period: 2026-03-31 · Number of holdings: 28
SABBY MANAGEMENT, LLC disclosed 28 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $45.1M and a quarterly turnover rate of 78.3%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "S"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/sabby-management-llc
Add 78462F953
+28.1% $5.3M
Trim 464287955
-53.8% -$8.6M
Add SPY
+716.1% $1.5M
Add 374396956
-16.3% $179.0K
Trim 00370M903
-51.9% -$1.3M
Trim TPST
-90.0% -$483.3K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 19.92% | +3.61% | +716.12% | |
| 2 | ✓ | Gevo INC | Stock-Other | 16.06% | +1.37% | -16.29% | |
| 3 | ✓ | Abivax SA | Stock-Other | 9.60% | -1.20% | -51.88% | |
| 4 | ✓ | Stock-Other | 7.33% | +1.45% | NEW | ||
| 5 | BCTXL | Briacell Therapeutics CORP | Stock-Other | 4.39% | +0.87% | NEW | |
| 6 | SNES | Senestech INC | Stock-Other | 4.01% | +0.15% | +3.78% | |
| 7 | ✓ | Big Tree Cloud Hldgs LTD | Stock-Other | 3.78% | +0.75% | NEW | |
| 8 | ✓ | Zevra Therapeutics INC | Stock-Other | 3.55% | +0.28% | +3.98% | |
| 9 | BCTX | Briacell Therapeutics CORP | Stock-Other | 3.47% | +0.69% | NEW | |
| 10 | ✓ | Spdr S&p 500 ETF Tr | ETF-Large Cap & Growth | 3.26% | +30.26% | +28.08% | |
| 11 | ✓ | Sidus Space INC | Stock-Other | 2.73% | +0.54% | NEW | |
| 12 | TC | Token Cat LTD | Stock-Other | 2.71% | +0.54% | NEW | |
| 13 | ✓ | Pop Culture Group Co LTD | Stock-Other | 2.25% | -0.13% | -30.54% | |
| 14 | MBRX | Moleculin Biotech INC | Stock-Other | 1.92% | +0.38% | NEW | |
| 15 | ✓ | Stock-Other | 1.78% | -0.27% | +35.04% | ||
| 16 | RKDA | Arcadia Biosciences INC | Stock-Other | 1.77% | +0.35% | NEW | |
| 17 | TRX | Trx Gold CORP | Stock-Other | 1.68% | +0.33% | NEW | |
| 18 | INM | Inmed Pharmaceuticals INC | Stock-Other | 1.59% | +0.01% | +9.24% | |
| 19 | CANF | Can Fite Biopharma Ltd-adr | Stock-Other | 1.48% | +0.29% | NEW | |
| 20 | ✓ | China Sxt Pharmaceuticals In | Stock-Other | 1.47% | +0.29% | NEW | |
| 21 | REVB | Revelation Biosciences INC | Stock-Other | 1.34% | +0.26% | NEW | |
| 22 | CLDI | Calidi Biotherapeutics INC | Stock-Other | 1.16% | +0.23% | NEW | |
| 23 | ✓ | Ishares Tr | Stock-Other | 0.83% | -6.51% | -53.85% | |
| 24 | BJDX | Bluejay Diagnostics INC | Stock-Other | 0.59% | +0.12% | NEW | |
| 25 | LYRA | Lyra Therapeutics INC | Stock-Other | 0.57% | -0.67% | -40.59% | |
| 26 | TPST | Tempest Therapeutics INC | Stock-Other | 0.33% | -0.68% | -90.00% | |
| 27 | BCTXZ | Briacell Therapeutics - 30 | Stock-Other | 0.32% | -0.05% | -22.26% | |
| 28 | BNBX | Bnb Plus CORP | Stock-Other | 0.10% | -0.08% | -74.92% |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 38% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 28 | $45.1M | 78 | |
| 2025-12-31 | 33 | $69.5M | 64 | 178462F24642873464287 |
| 2025-09-30 | 39 | $86.4M | 100 | 1464287278462F3464287 |
| 2025-06-30 | 43 | $55.1M | 0 | |
| 2025-03-31 | 46 | $34.0M | 100 | |
| 2024-12-31 | 27 | $76.9M | 0 | 1464287278462F321874A |
| 2024-09-30 | 42 | $186.4M | 0 | |
| 2024-06-30 | 39 | $148.7M | 0 | |
| 2024-03-31 | 55 | $173.3M | 0 | |
| 2023-12-31 | 56 | $100.0M | 0 | |
| 2023-09-30 | 84 | $136.6M | 0 | |
| 2023-06-30 | 89 | $122.2M | 0 | 1464287278462F310501E |
| 2023-03-31 | 89 | $114.8M | 0 | 178462F2464287310778Y |
| 2022-12-31 | 109 | $114.0M | 0 | |
| 2022-09-30 | 116 | $79.3M | 0 | |
| 2022-06-30 | 127 | $147.0M | 0 | 178462F2464287325400Q |
| 2022-03-31 | 147 | $669.7M | 0 | |
| 2021-12-31 | 189 | $687.8M | 0 | |
| 2021-09-30 | 184 | $739.9M | 0 | |
| 2021-06-30 | 162 | $709.3M | 84 | |
| 2021-03-31 | 156 | $513.9M | 100 | |
| 2020-12-31 | 106 | $521.7M | 84 | |
| 2020-09-30 | 132 | $669.9M | 71 | |
| 2020-06-30 | 103 | $498.2M | 100 | |
| 2020-03-31 | 89 | $240.6M | 100 | 181369Y278462F3464287 |
| 2019-12-31 | 71 | $360.7M | 100 | |
| 2019-09-30 | 93 | $185.6M | 100 | 178462F24642873464287 |
| 2019-06-30 | 88 | $79.5M | 100 | |
| 2019-03-31 | 80 | $208.2M | 100 | |
| 2018-12-31 | 124 | $454.6M | 98 | 178462F2464287329664W |
| 2018-09-30 | 124 | $781.5M | 69 | |
| 2018-06-30 | 138 | $647.2M | 100 | |
| 2018-03-31 | 156 | $840.8M | 100 | |
| 2017-12-31 | 161 | $1.1B | 91 | |
| 2017-09-30 | 164 | $1.5B | 61 | |
| 2017-06-30 | 216 | $1.5B | 73 | |
| 2017-03-31 | 257 | $1.9B | 100 | |
| 2016-12-31 | 293 | $1.7B | 90 | 1532457278462F3464287 |
| 2016-09-30 | 307 | $2.7B | 97 | |
| 2016-06-30 | 287 | $1.9B | 96 | 1532457278462F3464287 |
| 2016-03-31 | 294 | $2.0B | 80 | |
| 2015-12-31 | 315 | $1.8B | 60 | 15324572464287378462F |
| 2015-09-30 | 379 | $2.4B | 73 | 178462F24642873532457 |
| 2015-06-30 | 319 | $2.7B | 80 | 1532457278462F3464287 |
| 2015-03-31 | 286 | $2.4B | 100 | |
| 2014-12-31 | 234 | $3.2B | 75 | |
| 2014-09-30 | 254 | $2.6B | 100 | |
| 2014-06-30 | 252 | $2.3B | 98 | |
| 2014-03-31 | 232 | $1.8B | 100 | |
| 2013-12-31 | 216 | $1.6B | 86 | |
| 2013-09-30 | 194 | $1.5B | 89 | |
| 2013-06-30 | 169 | $1.5B | 0 |
Sabby Management, LLC's most significant position changes for 2026-03-31: Sold out: Ishares Tr; Sold out: ; Sold out: Empery Digital INC (EMPD); Sold out: Blink Charging Co (BLNK); Sold out: Bitcoin Depot INC.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | +30.3% | +28.08% | Add |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +3.6% | +716.12% | Add |
| 3 | ✓ | Gevo INC | +1.4% | -16.29% | Trim |
| 4 | ✓ | Zevra Therapeutics INC | +0.3% | +3.98% | Add |
| 5 | SNES | Senestech INC | +0.2% | +3.78% | Add |
| 6 | INM | Inmed Pharmaceuticals INC | 0% | +9.24% | Add |
| 7 | BCTXZ | Briacell Therapeutics - 30 | -0.1% | -22.26% | Trim |
| 8 | BNBX | Bnb Plus CORP | -0.1% | -74.92% | Trim |
| 9 | ✓ | Pop Culture Group Co LTD | -0.1% | -30.54% | Trim |
| 10 | ✓ | -0.3% | +35.04% | Add | |
| 11 | LYRA | Lyra Therapeutics INC | -0.7% | -40.59% | Trim |
| 12 | TPST | Tempest Therapeutics INC | -0.7% | -90.00% | Trim |
| 13 | ✓ | Abivax SA | -1.2% | -51.88% | Trim |
| 14 | ✓ | Ishares Tr | -6.5% | -53.85% | Trim |
| 15 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 16 | ✓ | — | EXIT | Sold out | |
| 17 | EMPD | Empery Digital INC | — | EXIT | Sold out |
| 18 | BLNK | Blink Charging Co | — | EXIT | Sold out |
| 19 | ✓ | Bitcoin Depot INC | — | EXIT | Sold out |
| 20 | ABVX | Abivax Sa-adr | — | EXIT | Sold out |
| 21 | ✓ | — | NEW | New buy | |
| 22 | ✓ | — | EXIT | Sold out | |
| 23 | BCTXL | Briacell Therapeutics CORP | — | NEW | New buy |
| 24 | ZONE | Cleancore Solutions Inc-cl B | — | EXIT | Sold out |
| 25 | ✓ | Big Tree Cloud Hldgs LTD | — | NEW | New buy |
| 26 | ✓ | Jiuzi Holdings INC | — | EXIT | Sold out |
| 27 | BCTX | Briacell Therapeutics CORP | — | NEW | New buy |
| 28 | ✓ | Globavend Holdings LTD | — | EXIT | Sold out |
| 29 | ✓ | Sidus Space INC | — | NEW | New buy |
| 30 | TC | Token Cat LTD | — | NEW | New buy |
| 31 | ✓ | Tian Ruixiang Hldgs LTD | — | EXIT | Sold out |
| 32 | QM30 | Nova Minerals Ltd-adr | — | EXIT | Sold out |
| 33 | MBRX | Moleculin Biotech INC | — | NEW | New buy |
| 34 | RKDA | Arcadia Biosciences INC | — | NEW | New buy |
| 35 | NUWE | Nuwellis INC | — | EXIT | Sold out |
| 36 | TRX | Trx Gold CORP | — | NEW | New buy |
| 37 | ✓ | Epicquest Educatn Grp Intl L | — | EXIT | Sold out |
| 38 | CANF | Can Fite Biopharma Ltd-adr | — | NEW | New buy |
| 39 | ✓ | China Sxt Pharmaceuticals In | — | NEW | New buy |
| 40 | REVB | Revelation Biosciences INC | — | NEW | New buy |
| 41 | ✓ | Reviva Pharmaceutcls Hldgs INC | — | EXIT | Sold out |
| 42 | CLDI | Calidi Biotherapeutics INC | — | NEW | New buy |
| 43 | PMCB | Pharmacyte Biotech INC | — | EXIT | Sold out |
| 44 | BJDX | Bluejay Diagnostics INC | — | NEW | New buy |
| 45 | OGEN | Oragenics INC | — | EXIT | Sold out |
| 46 | LMFA | Lm Funding America INC | — | EXIT | Sold out |
| 47 | ✓ | Eos Energy Enterprises INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-15 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-15 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-02-15 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-09-27 | Amendment | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-16 | Amendment | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-18 | Amendment | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-14 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-14 | Amendment | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001812285
Total reported value
$45.0M
96 stks
2024-06-30
Stale — no recent filing
AUM within 0.2% of this institution
CIK 0001879167
Total reported value
$45.2M
71 stks
2024-09-30
Stale — no recent filing
AUM within 0.2% of this institution
CIK 0001138897
Total reported value
$45.2M
10 stks
2025-09-30
Stale — no recent filing
AUM within 0.3% of this institution
Institutions with overlapping top holdings
CIK 0001731358
Total reported value
$425.2M
150 stks
2026-03-31
3 of the top 5 holdings overlap, including Ss Spdr S&p 500 ETF Trust-us
CIK 0000919185
Total reported value
$3.1B
378 stks
2026-03-31
2 of the top 5 holdings overlap
CIK 0001529090
Total reported value
$44.1B
32 stks
2026-03-31
2 of the top 5 holdings overlap